Impact of COVID-19 on Acute Myocardial Infarction Care
- PMID: 36863814
- PMCID: PMC9973541
- DOI: 10.1016/j.hfc.2022.08.004
Impact of COVID-19 on Acute Myocardial Infarction Care
Abstract
The global health crisis caused by the COVID-19 pandemic has evolved rapidly to overburden health care organizations around the world and has resulted in significant morbidity and mortality. Many countries have reported a substantial and rapid reduction in hospital admissions for acute coronary syndromes and percutaneous coronary intervention. The reasons for such abrupt changes in health care delivery are multifactorial and include lockdowns, reduction in outpatient services, reluctance to seek medical attention for fear of contracting the virus, and restrictive visitation policies adopted during the pandemic. This review discusses the impact of COVID-19 on important aspects of acute MI care.
Keywords: COVID-19; Fibrinolytic therapy; Myocardial infarction; NSTEMI; Percutaneous coronary intervention; STEMI.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr S. Garcia is a consultant for Medtronic, Edwards Lifesciences, BSCI, and Abbott Vascular; has received institutional research grants from Edwards Lifesciences, Abbott Vascular, Gore, and BSCI; and is a proctor for Edwards Lifesciences. The other authors have nothing to disclose.
Figures
References
-
- Benjamin E.J., Muntner P., Alonso A., et al. Heart disease and stroke statistics-2019 update: a report from the american heart association. Circulation. 2019;139(10):e56–e528. - PubMed
-
- Solomon M.D., McNulty E.J., Rana J.S., et al. The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020;383(7):691–693. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
